Welcome to Penumbra, Inc.’s Q4 2024 Earnings Conference Call
Date: February 18, 2025
Time: 4:30 PM ET
Company Participants:
Cecilia Furlong – Director of Business Development and Investor Relations
Adam Elsesser – Chairman & Chief Executive Officer
Maggie Yuen – Chief Financial Officer
Jason Mills – Executive Vice President of Strategy
Conference Call Participants:
Larry Biegelsen – Wells Fargo Securities
Robert Marcus – JPMorgan
Pito Chickering – Deutsche Bank
Bill Plovanic – Canaccord
Richard Newitter – Truist Securities
Samantha Kurtz – Piper Sandler
Michael Sarcone – Jefferies
Ryan Zimmerman – BTIG
Shagun Singh – RBC Capital Markets
Michael Kratky – Leerink Partners
Operator: Good afternoon. My name is Rob and I will be your conference operator today.
Penumbra, Inc. recently held their Q4 2024 Earnings Conference Call where top executives discussed the company’s financial performance and strategies for the future. With the participation of various conference call participants, including analysts from leading financial institutions, the call provided valuable insights into Penumbra’s market position and potential growth opportunities.
During the call, Cecilia Furlong, Adam Elsesser, Maggie Yuen, and Jason Mills highlighted key achievements and challenges faced by the company in the past quarter. They also discussed their plans for innovation and expansion in the coming months, emphasizing their commitment to delivering value to shareholders and customers alike.
Analysts such as Larry Biegelsen, Robert Marcus, and Samantha Kurtz posed insightful questions regarding Penumbra’s financial outlook and competitive landscape. Their inquiries shed light on potential risks and opportunities that could impact the company’s performance in the near future.
Overall, the Q4 2024 Earnings Conference Call provided a comprehensive overview of Penumbra, Inc.’s operations and prospects, setting the stage for continued growth and success in the global market.
How This Will Affect Me:
As a potential investor or current shareholder, the insights shared during Penumbra, Inc.’s conference call can help you make informed decisions about your investment portfolio. Understanding the company’s financial performance and strategic direction can guide you in assessing the potential risks and rewards of investing in Penumbra, Inc.
How This Will Affect the World:
Penumbra, Inc.’s growth and innovation in the medical technology sector have the potential to impact the world by improving healthcare outcomes and advancing medical research. Their focus on developing cutting-edge solutions for critical medical conditions can contribute to advancements in patient care and treatment options globally.
Conclusion:
The Q4 2024 Earnings Conference Call held by Penumbra, Inc. showcased the company’s commitment to excellence and growth in the competitive market. With a strong leadership team and strategic vision, Penumbra, Inc. is well-positioned to drive innovation and create value for stakeholders in the years to come.
